. "Appendix D: Biographic Information on the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II." A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration. Washington, DC: The National Academies Press, 2011.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration
the National Academy of Engineering and has participated in several National Research Council activities, including being a speaker at a Workshop on Innovation and Invention in Medical Devices and a member of the Committee to Develop a Research Agenda for Test Methods and Models to Simulate Accelerated Aging of Infrastructure Materials. Dr. Watson earned his PhD from the University of Texas Southwestern Medical Center at Dallas.